UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Journal of clinical oncology, 2015-12, Vol.33 (34), p.4007-4014

2015

Volltextzugriff (PDF)

Essentials of Online Teaching: A Standards-Based Guide

1, 2017

Volltextzugriff (PDF)

Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study

Journal of neuro-oncology, 2016-08, Vol.129 (1), p.131-138

2016

Volltextzugriff (PDF)

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Expanded access in North America

The Prostate, 2015-06, Vol.75 (8), p.836-844

2015

Volltextzugriff (PDF)

Molecular epidemiology of an extended multiple-species OXA-48 CPE outbreak in a hospital ward in Ireland, 2018–2019

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2021-01, Vol.1 (1), p.e54-e54, Article e54

2021

Volltextzugriff (PDF)

Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA)

International journal of epidemiology, 2018-10, Vol.47 (5), p.1398-1398l

2018

Volltextzugriff (PDF)

Fr499 RATES OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES INFECTION DURING THE COVID-19 PANDEMIC IN A TERTIARY HEALTHCARE SETTING

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-333-S-333

2021

Volltextzugriff (PDF)

Assessing Economies of Scale in Public Hospitals

Economic papers (Economic Society of Australia), 2011-09, Vol.30 (3), p.341-347

2011

Volltextzugriff (PDF)

The role of healthcare staff COVID-19 screening in infection prevention & control

The Journal of infection, 2020-09, Vol.81 (3), p.e53-e54

2020

Volltextzugriff (PDF)

Switching Between Standard Pointing Methods with Current and Emerging Computer Form Factors

Proceedings of the 2022 CHI Conference on Human Factors in Computing Systems, 2022, p.1-14

2022

Volltextzugriff (PDF)

DRG Grouping and ICD-10-CM/PCS

Journal of AHIMA, 2015-07, Vol.86 (7), p.56

Foley, Margaret M

2015

Volltextzugriff (PDF)

Surveillance of common infections in the early period after renal transplantation in a national center: 2014‐2017

Transplant infectious disease, 2020-06, Vol.22 (3), p.e13261-n/a

2020

Volltextzugriff (PDF)

Policy agenda for the next decade: creating a path for graceful evolution and harmonized classifications and terminologies used for encoding health information in electronic environments

Perspectives in health information management, 2009-09, Vol.6, p.1c-1c

2009

Volltextzugriff (PDF)

CPE in Beaumont Hospital – Trying to understand an increasing and challenging pathogen

Access microbiology, 2020-02, Vol.2 (2)

2020

Volltextzugriff (PDF)

Common and rare EGFR mutations ( EGFR m) in the RADIANT trial: Final follow-up with 5 year data

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7539-7539

2015

Volltextzugriff (PDF)

Loss of Immunoreactivity for Human Calmodulin-Like Protein is an Early Event in Breast Cancer Development

Neoplasia (New York, N.Y.), 1999-08, Vol.1 (3), p.220-225

1999

Volltextzugriff (PDF)

Phase I dose escalation study of ASP8273, a mutant-selective irreversible EGFR inhibitor, in subjects with EGFR mutation positive NSCLC

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8083-8083

2015

Volltextzugriff (PDF)

Final follow-up (f/u) results from RADIANT: A randomized double blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection in patients (pts) with stage IB–IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7540-7540

2015

Volltextzugriff (PDF)

The (Un)Making of a Reader

Language arts, 2000-07, Vol.77 (6), p.506-511

FOLEY, MARGARET M.

2000

Volltextzugriff (PDF)

Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC): RADIANT trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7535-7535

2014

Volltextzugriff (PDF)

Adjuvant erlotinib (E) versus placebo (P) in non-small cell lung cancer (NSCLC) patients (pts) with tumors carrying EGFR- sensitizing mutations from the RADIANT trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7513-7513

2014

Volltextzugriff (PDF)

Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5051-5051

2014

Volltextzugriff (PDF)

Assessing Economies of Scale in Public Hospitals: ECONOMIES OF SCALE IN HOSPITALS

Economic papers (Economic Society of Australia), 2011-09, Vol.30 (3), p.341-347

2011

Volltextzugriff (PDF)

Comparing Smartphone Speech Recognition and Touchscreen Typing for Composition and Transcription

Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems, 2020, p.1-11

2020

Volltextzugriff (PDF)

1 – 25 von 292

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(235)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(292)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(131)
Humans
(95)
Female
(50)
Male
(46)
Adult
(29)
Middle Aged
(28)
Animals
(24)
Aged
(22)
Neurosciences & Neurology
(22)
Biological And Medical Sciences
(19)
Clinical Neurology
(18)
General & Internal Medicine
(16)
Medical Sciences
(15)
Young Adult
(14)
Adolescent
(13)
Child
(13)
Higher & Further Education, Tertiary Education
(13)
Open Learning, Home Learning, Distance Education
(13)
Pediatrics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Essentials of Online Teaching: A Standards-Based Guide

Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Expanded access in North America

Molecular epidemiology of an extended multiple-species OXA-48 CPE outbreak in a hospital ward in Ireland, 2018–2019

Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA)

Fr499 RATES OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES INFECTION DURING THE COVID-19 PANDEMIC IN A TERTIARY HEALTHCARE SETTING

Assessing Economies of Scale in Public Hospitals

The role of healthcare staff COVID-19 screening in infection prevention & control

Switching Between Standard Pointing Methods with Current and Emerging Computer Form Factors

DRG Grouping and ICD-10-CM/PCS

Surveillance of common infections in the early period after renal transplantation in a national center: 2014‐2017

Policy agenda for the next decade: creating a path for graceful evolution and harmonized classifications and terminologies used for encoding health information in electronic environments

CPE in Beaumont Hospital – Trying to understand an increasing and challenging pathogen

Common and rare EGFR mutations ( EGFR m) in the RADIANT trial: Final follow-up with 5 year data

Loss of Immunoreactivity for Human Calmodulin-Like Protein is an Early Event in Breast Cancer Development

Phase I dose escalation study of ASP8273, a mutant-selective irreversible EGFR inhibitor, in subjects with EGFR mutation positive NSCLC

Final follow-up (f/u) results from RADIANT: A randomized double blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection in patients (pts) with stage IB–IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC)

The (Un)Making of a Reader

Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC): RADIANT trial

A randomized, double-blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC): RADIANT results

Adjuvant erlotinib (E) versus placebo (P) in non-small cell lung cancer (NSCLC) patients (pts) with tumors carrying EGFR- sensitizing mutations from the RADIANT trial

Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel

Assessing Economies of Scale in Public Hospitals: ECONOMIES OF SCALE IN HOSPITALS

Comparing Smartphone Speech Recognition and Touchscreen Typing for Composition and Transcription

Suchergebnisse filtern